These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 26030250)

  • 1. Determination of genotypes using a fully automated molecular detection system.
    Spizz G; Chen Z; Li P; McGuire IC; Klimkiewicz P; Zysling D; Yasmin R; Hungerford W; Thomas B; Wilding G; Mouchka G; Young L; Zhou P; Montagna RA
    Arch Pathol Lab Med; 2015 Jun; 139(6):805-11. PubMed ID: 26030250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-Validation of High-Resolution Melting Analysis-Based Genotyping Platform.
    Langaee T; Stauffer L; Galloway C; Solayman MH; Cavallari L
    Genet Test Mol Biomarkers; 2017 Apr; 21(4):259-264. PubMed ID: 28384046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated amplification microarray system in a lateral flow cell for warfarin genotyping from saliva.
    Sebastian T; Cooney CG; Parker J; Qu P; Perov A; Golova JB; Pozza L; Iwasiow RM; Holmberg R
    Clin Chim Acta; 2014 Feb; 429():198-205. PubMed ID: 24360850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics: accessing important alleles by imputation from commercial genome-wide SNP arrays.
    Liboredo R; Pena SD
    Genet Mol Res; 2014 Jul; 13(3):5713-21. PubMed ID: 25117329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvements in CYP2C9 Genotyping Accuracy Are Needed: A Report of the First Proficiency Testing for Warfarin-related CYP2C9 and VKORC1 Genotyping in China.
    Lin G; Yi L; Zhang K; Sun Y; Wang L; Zhang R; Xie J; Li J
    J Cardiovasc Pharmacol; 2015 Aug; 66(2):129-34. PubMed ID: 25815675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated Classification and Cluster Visualization of Genotypes Derived from High Resolution Melt Curves.
    Kanderian S; Jiang L; Knight I
    PLoS One; 2015; 10(11):e0143295. PubMed ID: 26605797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole Blood PCR Amplification with Pfu DNA Polymerase and Its Application in Single-Nucleotide Polymorphism Analysis.
    Liu EP; Wang Y; He XH; Guan JJ; Wang J; Qin ZH; Sun WP
    Genet Test Mol Biomarkers; 2015 Nov; 19(11):610-6. PubMed ID: 26360116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of CYP2C9 and VKORC1 genetic polymorphisms upon warfarin dose requirements in Egyptian patients with acute coronary syndrome.
    Ghozlan MF; Foad DA; Darwish YW; Saad AA
    Blood Coagul Fibrinolysis; 2015 Jul; 26(5):499-504. PubMed ID: 25699611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SYBR Green-based real-time PCR assay for detection of VKORC1 and CYP2C9 polymorphisms that modulate warfarin dose requirement.
    Huang SW; Li Q; Zhu SY; Li L; Xiong F; Jia YK; Xu XM
    Clin Chem Lab Med; 2009; 47(1):26-31. PubMed ID: 19117406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon® probes.
    Howard R; Leathart JB; French DJ; Krishan E; Kohnke H; Wadelius M; van Schie R; Verhoef T; Maitland-van der Zee AH; Daly AK; Barallon R
    Clin Chim Acta; 2011 Nov; 412(23-24):2063-9. PubMed ID: 21827742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin dose.
    King CR; Porche-Sorbet RM; Gage BF; Ridker PM; Renaud Y; Phillips MS; Eby C
    Am J Clin Pathol; 2008 Jun; 129(6):876-83. PubMed ID: 18480003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationalized DNA sequencing-based protocol for genotyping patients receiving coumarin therapy.
    Rakicevic LB; Kusic-Tisma JS; Kovac MK; Backovic DT; Radojkovic DP
    Scand J Clin Lab Invest; 2013 Sep; 73(6):523-7. PubMed ID: 23806093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affordable hands-on DNA sequencing and genotyping: an exercise for teaching DNA analysis to undergraduates.
    Shah K; Thomas S; Stein A
    Biochem Mol Biol Educ; 2013; 41(6):388-95. PubMed ID: 24019265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy].
    Liu Y; Zhong SL; Tan HH; Yang M; Fei HW; Yu XY; Lin SG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):929-35. PubMed ID: 22321278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin.
    Vecsler M; Loebstein R; Almog S; Kurnik D; Goldman B; Halkin H; Gak E
    Thromb Haemost; 2006 Feb; 95(2):205-11. PubMed ID: 16493479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of gene polymorphisms with the risk of warfarin bleeding complications at therapeutic INR in patients with mechanical cardiac valves.
    An SH; Lee KE; Chang BC; Gwak HS
    J Clin Pharm Ther; 2014 Jun; 39(3):314-8. PubMed ID: 24602049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of the high resolution melting method for genotyping CYP2C9*3 (1075A/C, rs1057910) and VKORC1 (-1639A/G, rs9923231)].
    Cui GL; Ding H; Xu YJ; Chen C; Wang DW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jun; 40(6):477-81. PubMed ID: 22943641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of performance of three commercial platforms for warfarin sensitivity genotyping.
    Babic N; Haverfield EV; Burrus JA; Lozada A; Das S; Yeo KT
    Clin Chim Acta; 2009 Aug; 406(1-2):143-7. PubMed ID: 19545555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype frequencies of VKORC1 and CYP2C9 in native and Mestizo populations from Mexico, potential impact for coumarin dosing.
    Villegas-Torres B; Sánchez-Girón F; Jaramillo-Villafuerte K; Soberón X; Gonzalez-Covarrubias V
    Gene; 2015 Mar; 558(2):235-40. PubMed ID: 25560189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9-mediated dose requirements of vitamin K antagonist therapy: a pilot study.
    Brunner-Ziegler S; Jilma B; Magirr D; Sunder-Plassmann R; Giurgea GA; Hammer A; Margeta C; Brunner M; Koppensteiner R; Mannhalter C
    Br J Haematol; 2014 Nov; 167(4):547-53. PubMed ID: 25142093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.